I was a bit nonplussed by Mr. Hakim's comments relating to Puracap. I am hard pressed to understand why he did not know whether Puracap would have to abide by the license agreement after the purchase by Puracap of Epic. I think that is reason no. 1 for the sell off. In the end, I understand the ability of ELTP to bring the drug to market has to weigh heavily on weather the drug is approved. So, in that regard, a short delay, while that issue is squared away, could be a benefit. In the meantime, as I mentioned yesterday, I expect many more 10-20% daily swings and more opportunities to pick up free shares along the way. No question about it we will continue to have some volatile days.